Which drugs does patent 5,780,454 protect, and when does it expire?
Patent 5,780,454 protects VELCADE and is included in one NDA. There has been one Paragraph IV challenge on Velcade.
Protection for VELCADE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty-seven patent family members in twenty-five countries.